References
- Antkowiak R, Antkowiak Ł, Grzegorczyn S et al. (2020) Efficacy of intra-arterial lidocaine infusion in the treatment of ceruleininduced acute pancreatitis. Adv Clin Exp Med 29:587–595.
https://doi.org/10.17219/acem/121932 - Antkowiak R, Bialecki J, Chabowski M et al. (2022) Treatment of microcirculatory disturbances in acute pancreatitis: Where are we now? Pancreas 51:415–421.
https://doi.org/10.1097/MPA.0000000000002044 - Arsyad A, Dobson GP (2016) Lidocaine relaxation in isolated rat aortic rings is enhanced by endothelial removal: Possible role of Kv, KATP channels and A2a receptor crosstalk. BMC Anesthesiol 16:121.
https://doi.org/10.1186/s12871-016-0286-y - Buyukberber M, Savaş MC, Bagci C et al. (2009) Therapeutic effect of caffeic acid phenethyl ester on cerulein-induced acute pancreatitis. World J Gastroenterol 15:5181–5185.
https://doi.org/10.3748/wjg.15.5181 - Cuthbertson CM, Christophi C (2006) Disturbances of the microcirculation in acute pancreatitis. Br J Surg 93:518–530.
https://doi.org/10.1002/bjs.5316 - Ding S-P, Li J-C, Jin C (2003) A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J Gastroenterol 9:584–589.
https://doi.org/10.3748/wjg.v9.i3.584 - Dobosz M, Mionskowska L, Hac S et al. (2004) Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats. World J Gastroenterol 10:2553–2556.
https://doi.org/10.3748/wjg.v10.i17.2553 - Ethridge RT, Hashimoto K, Chung DH et al. (2002) Selective inhibition of NF-kappaB attenuates the severity of cerulein-induced acute pancreatitis. J Am Coll Surg 195:497–505.
https://doi.org/10.1016/s1072-7515(02)01222-x - Hackert T, Werner J, Gebhard MM et al. (2004) Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis. Surgery 135:131–138.
https://doi.org/10.1016/j.surg.2003.08.001 - Iannuzzi JP, King JA, Leong JH et al. (2022) Global incidence of acute pancreatitis is increasing over time: A systematic review and meta-analysis. Gastroenterology 162:122–134.
https://doi.org/10.1053/j.gastro.2021.09.043 - Ismail OZ, Bhayana V (2017) Lipase or amylase for the diagnosis of acute pancreatitis? Clin Biochem 50:1275–1280.
https://doi.org/10.1016/j.clinbiochem.2017.07.003 - Ke L, Ni HB, Tong ZH et al. (2014) Efficacy of continuous regional arterial infusion with low-molecular-weight heparin for severe acute pancreatitis in a porcine model. Shock 41:443–448.
https://doi.org/10.1097/SHK.0000000000000129 - Kim M-J, Kim D-U, Choi J-W et al. (2020) Silymarin attenuates the severity of cerulein-induced acute pancreatitis. Pancreas 49:89–95.
https://doi.org/10.1097/MPA.0000000000001453 - Kim KH, Lee MG, Kim DG (1996) The cholecystokinin receptor antagonist L-364,718 reduces taurocholate-induced pancreatitis in rats. Int J Pancreatol 20:205–211.
https://doi.org/10.1007/BF02803770 - Ning F, Wang X, Shang L et al. (2015) Low molecular weight heparin may prevent acute lung injury induced by sepsis in rats. Gene 557:88–91.
https://doi.org/10.1016/j.gene.2014.12.018 - Percie du Sert N, Hurst V, Ahluwalia A et al. (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18:e3000410.
https://doi.org/10.1371/journal.pbio.3000410 - Podda M, Murzi V, Marongiu P et al. (2024) Effectiveness and safety of low molecular weight heparin in the management of acute pancreatitis: A systematic review and meta-analysis. World J Emerg Surg 19:30.
https://doi.org/10.1186/s13017-024-00558-3 - Qiu Q, Li GJ, Tang L et al. (2019) The efficacy of low molecular weight heparin in severe acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials. J Dig Dis 20:512–522.
https://doi.org/10.1111/1751-2980.12815 - Satoh K, Kamada S, Kumagai M et al. (2015) Effect of lidocaine on swine lingual and pulmonary arteries. J Anesth 29:529–534.
https://doi.org/10.1007/s00540-014-1965-9 - Tozlu M, Kayar Y, İnce AT et al. (2019) Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled, open-label study. Turk J Gastroenterol 30:81–87.
https://doi.org/10.5152/tjg.2018.18583